Abbott India Ltd.
| BSE: 500488 | Sector: Health care |
| NSE: ABBOTINDIA | ISIN Code: INE358A01014 |
| BSE 00:00 | 12 May | 16114.80 |
-78.75 (-0.49%) |
OPEN
16166.90 |
HIGH
16300.00 |
LOW
16042.20 |
| NSE 00:00 | 12 May | 16158.40 |
-46.60 (-0.29%) |
OPEN
16202.00 |
HIGH
16299.00 |
LOW
16051.05 |
| OPEN | 16166.90 |
| PREVIOUS CLOSE | 16193.55 |
| VOLUME | 868 |
| 52-Week high | 18450.00 |
| 52-Week low | 13970.10 |
| P/E | 52.75 |
| Mkt Cap.(Rs cr) | 34,244 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Abbott India Ltd. (ABBOTINDIA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 1016.25 | -14.55 | -1.41 | 13266.48 |
| Cipla | 898.70 | 7.95 | 0.89 | 12659.15 |
| Sun Pharma.Inds. | 702.65 | -5.20 | -0.73 | 12531.93 |
| Dr Reddy's Labs | 5302.00 | 8.40 | 0.16 | 11850.40 |
| Lupin | 1210.75 | 13.15 | 1.10 | 11025.66 |
| Apollo Hospitals | 3196.50 | -62.80 | -1.93 | 9794.50 |
| Glenmark Pharma. | 623.85 | -0.70 | -0.11 | 6712.63 |
| Alkem Lab | 2994.65 | -37.70 | -1.24 | 6677.08 |
| Cadila Health. | 646.95 | 17.25 | 2.74 | 6347.40 |
| Torrent Pharma. | 2725.65 | 10.75 | 0.40 | 6168.44 |
| Divi's Lab. | 4061.25 | -13.40 | -0.33 | 5310.57 |
| Ipca Labs. | 2136.55 | -23.65 | -1.09 | 4337.82 |
| Piramal Enterp. | 1694.60 | 2.90 | 0.17 | 4219.19 |
| Alembic Pharma | 950.90 | -1.85 | -0.19 | 4132.55 |
| Abbott India | 16114.80 | -78.75 | -0.49 | 4093.14 |
| Glaxosmi. Pharma | 1479.45 | 4.00 | 0.27 | 3224.68 |
| Jubilant Pharmo | 850.45 | 3.00 | 0.35 | 3139.90 |
| Sanofi India | 7751.10 | -102.25 | -1.30 | 2901.90 |
| Laurus Labs | 484.30 | -7.10 | -1.44 | 2797.34 |
| Gland Pharma | 2858.60 | -7.55 | -0.26 | 2633.24 |
Quick Links for Abbott India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
